Patient Selection for Drip and Ship Thrombolysis in Acute Ischemic Stroke

South Med J. 2015 Jul;108(7):393-8. doi: 10.14423/SMJ.0000000000000306.

Abstract

Objectives: The drip and ship model is a method used to deliver thrombolysis to acute stroke patients in facilities lacking onsite neurology coverage. We sought to determine whether our drip and ship population differs from patients treated directly at our stroke center (direct presenters).

Methods: We retrospectively reviewed consecutive patients who received thrombolysis at an outside facility with subsequent transfer to our center between 2009 and 2011. Patients received thrombolysis after telephone consultation with a stroke specialist. We examined demographics, vascular risk factors, laboratory values, and stroke severity in drip and ship patients compared with direct presenters.

Results: Ninety-six patients were identified who received thrombolysis by drip and ship compared with 212 direct presenters. The two groups did not differ with respect to sex, ethnicity, vascular risk factors, or admission glucose. The odds ratio (OR) of arriving at our hospital as a drip and ship for someone 80 years or older was 0.31 (95% confidence interval [CI] 0.15-0.61, P < 0.001). Only 21% of drip and ship patients were black versus 38% of direct presenters (OR 0.434, 95% CI 0.25-0.76, P = 0.004). Even after stratifying by age (<80 vs ≥80), a smaller proportion of drip and ship patients were black (OR 0.44, 95% CI 0.24-0.81, P = 0.008). Furthermore, we found that fewer black patients with severe strokes arrived by drip and ship (OR 0.33, 95% CI 0.11-0.98, P = 0.0028).

Conclusions: Our study showed that a smaller proportion of blacks and older adults arrived at our center by the drip and ship model. This may reflect differences in how patients are selected for thrombolysis and transfer to a higher level of care.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Black People
  • Brain Ischemia* / diagnosis
  • Brain Ischemia* / epidemiology
  • Brain Ischemia* / therapy
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Humans
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Neurology / methods*
  • Outcome Assessment, Health Care
  • Patient Selection
  • Patient Transfer* / methods
  • Patient Transfer* / organization & administration
  • Remote Consultation / methods*
  • Retrospective Studies
  • Stroke* / diagnosis
  • Stroke* / epidemiology
  • Stroke* / therapy
  • Thrombolytic Therapy / methods*
  • Time Factors
  • Tissue Plasminogen Activator / administration & dosage*
  • United States / epidemiology

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator